Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.

Oncogene - 16 Mar 2000

Di Renzo M F, Olivero M, Martone T, Maffe A, Maggiora P, Stefani A D, Valente G, Giordano S, Cortesina G, Comoglio P M

Abstract excerpt

A metastatic cancer develops by accumulation of mutations in genes that control growth, survival and spreading. The latter genes have not yet been identified. In lymph node metastases of head and neck squamous cell carcinomas (HNSCC), we found mutations in the MET oncogene, which encodes the tyro...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Carcinoma, Squamous Cell
Share to MET gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Lymphatic Metastasis

Share to Mutation

Share to Proto-Oncogene Proteins c-met

Share to RNA, Neoplasm

Source

Identifiers

PMID: 10734314
DOI: 10.1038/sj.onc.1203455

Genes

MET

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10734314-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.PMID 10734314Read ↗

Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.Semantic proximity Read ↗

Roles for growth factors and mutations in metastatic dissemination.Semantic proximity Read ↗

MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.Semantic proximity Read ↗

MET in human cancer: germline and somatic mutationsSemantic proximity Read ↗

A point mutation in the MET oncogene abrogates metastasis without affecting transformationSemantic proximity Read ↗

Understanding c-MET signalling in squamous cell carcinoma of the head & neckSemantic proximity Read ↗

Genetic determinants of cancer metastasis.Semantic proximity Read ↗

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.Semantic proximity Read ↗

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.Semantic proximity Read ↗

Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.Semantic proximity Read ↗

Role of c-MET in upper aerodigestive malignancies--from biology to novel therapies.Semantic proximity Read ↗

Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.